Logo image
Night blindness in Sorsby's fundus dystrophy reversed by vitamin A
Journal article   Peer reviewed

Night blindness in Sorsby's fundus dystrophy reversed by vitamin A

Samuel G Jacobson, Artur V Cideciyan, Gopalakrishnan Regunath, Francisco J Rodriguez, Kimberlie Vandenburgh, Val C Sheffield and Edwin M Stone
Nature genetics, Vol.11(1), pp.27-32
09/1995
DOI: 10.1038/ng0995-27
PMID: 7550309

View Online

Abstract

Sorsby's fundus dystrophy (SFD) is an autosomal dominant retinal degeneration caused by mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) gene. Mechanisms of the visual loss in SFD, however, remain unknown. In a SFD family with a novel TIMP3 point mutation, we tested a hypothesis that their night blindness is due to a chronic deprivation of vitamin A at the level of the photoreceptors caused by a thickened membrane barrier between the photoreceptor layer and its blood supply. Vitamin A at 50,000 IU/d was administered orally. Within a week, the night blindness disappeared in patients at early stages of disease. Nutritional night blindness is thus part of the pathophysiology of this genetic disease and vitamin A supplementation can lead to dramatic restoration of photoreceptor function.
Night Blindness - drug therapy Night Blindness - metabolism Bruch Membrane - pathology Humans Middle Aged Night Blindness - etiology Male Retinal Rod Photoreceptor Cells - blood supply Retinal Degeneration - metabolism Vitamin A - administration & dosage Polymorphism, Single-Stranded Conformational Bruch Membrane - drug effects DNA Mutational Analysis Vitamin A - pharmacokinetics Night Blindness - pathology Adult Female Eye Proteins - genetics Diffusion Scotoma - drug therapy Tissue Inhibitor of Metalloproteinase-3 Retinal Degeneration - genetics Proteins - genetics Point Mutation Scotoma - etiology Vitamin A - therapeutic use Pedigree Retinal Degeneration - pathology Bruch Membrane - metabolism Fundus Oculi Retinal Degeneration - complications

Details

Logo image